BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 15373195)

  • 1. [Endocrine therapy for localized or locally advanced prostate cancer].
    Fontaine E; Ruffion A; Staerman F
    Prog Urol; 2004 Jun; 14(3):433-6. PubMed ID: 15373195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
    Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T;
    Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine treatment of prostate cancer.
    Tammela T
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of endocrine therapy in the management of local and distant recurrence of prostate cancer following radical prostatectomy or radiation therapy.
    Mayer FJ; Crawford ED
    Urol Clin North Am; 1994 Nov; 21(4):707-15. PubMed ID: 7974899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer.
    McLeod DG; Iversen P; See WA; Morris T; Armstrong J; Wirth MP;
    BJU Int; 2006 Feb; 97(2):247-54. PubMed ID: 16430622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between re-biopsy one year after endocrine therapy and long-term prognosis in localized prostate cancer].
    Kameoka H; Katayose K; Kumakawa K; Shiraiwa Y; Uchida H; Takahashi Y; Yazaki J; Yamaguchi O
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):57-63. PubMed ID: 15675583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neoadjuvant endocrine therapy in patients with locally advanced prostate cancer].
    Maeda O; Meguro N; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
    Hinyokika Kiyo; 1996 Oct; 42(10):821-7. PubMed ID: 8951482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical impact of neoadjuvant treatment to radical prostatectomy in locally advanced prostatic cancer].
    Villavicencio H; Laguna P; Ponce de Léon J
    Actas Urol Esp; 1994 May; 18 Suppl():404-8. PubMed ID: 8073926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radical prostatectomy and adjuvant endocrine treatment of prostatic cancer with lymphatic metastasis?].
    Schröder FH
    Urologe A; 1991 Nov; 30(6):417-22. PubMed ID: 1722923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Future prospects for primary hormone therapy in localized and locally advanced prostate cancer].
    Akaza H; Hirao Y; Labrie F; Soloway MS
    Hinyokika Kiyo; 2003 Dec; 49(12):771-7. PubMed ID: 14978964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preliminary results of radical surgery and radiotherapy of locally advanced prostate cancer (basal PSA >50 ng/ml)].
    Kaprin AD; Khmelevskiĭ EV; Fadeev AV
    Vopr Onkol; 2007; 53(4):479-81. PubMed ID: 17969415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer.
    Arcangeli G; Strigari L; Arcangeli S; Petrongari MG; Saracino B; Gomellini S; Papalia R; Simone G; De Carli P; Gallucci M
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):975-82. PubMed ID: 19395188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Locally advanced prostate cancer: definition, prognosis and treatment].
    Plantade A; Massard C; de Crevoisier R; Fizazi K
    Bull Cancer; 2007 Jul; 94(7 Suppl):F50-61. PubMed ID: 17845994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cancer of the prostate: what treatment for what stage?].
    Vanden Bossche M
    Rev Med Brux; 1999 Sep; 20(4):A206-11. PubMed ID: 10523894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical and medical treatment for localized prostate cancer].
    Kawai K
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1002-5. PubMed ID: 17637535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer: non-metastatic.
    Wilt T
    Clin Evid; 2002 Jun; (7):812-23. PubMed ID: 12230707
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer.
    Hennenfent BR
    Br J Urol; 1998 Jul; 82(1):166. PubMed ID: 9698691
    [No Abstract]   [Full Text] [Related]  

  • 18. [Medical castration in the treatment of locally advanced or metastatic prostate cancer: an update].
    Drouin SJ; Rouprêt M; Davin JL; Soulié M
    Prog Urol; 2009 Apr; 19 Suppl 1():S15-9. PubMed ID: 19465332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial to evaluate radiotherapy +/- endocrine therapy versus endocrine therapy alone for PSA failure after radical prostatectomy: Japan Clinical Oncology Group Study JCOG 0401.
    Yokomizo A; Kawamoto H; Nihei K; Ishizuka N; Kakehi Y; Tobisu K; Naito S;
    Jpn J Clin Oncol; 2005 Jan; 35(1):34-6. PubMed ID: 15681602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is maximal androgenic blockade necessary in the treatment of prostatic cancer?].
    Matveev BP; Bukharkin BV
    Urologiia; 2003; (6):6-10. PubMed ID: 14708235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.